GlaxoSmithKline is buying a U.S. biotechnology company that is researching resveratrol, the chemical compound found in red wine that may retard the aging process. The CEO of the company says that “drugs that mimic resveratrol, by activating enzymes called sirtuins, could ‘treat in a safe, natural new way, many of the major killers of western society.'” We can’t wait to see the commercials that GSK puts out for this one.
Glaxo Buys Aging Retardation Drug Company
By cwalters April 24, 2008
More From Consumerist
- Doctors Not Happy After Drug Goes From $13.50/Tablet To $750 Overnight
- Nearly A Year After Recall, Alli Weight-Loss Pills Return To Stores
- Pharmaceutical Companies Using Fitness Trackers To Collect Data On Drug Trials, Other Research
- Why Does A Tube Of Cold Sore Cream Cost $2,500?
- Tyson To Further Cut Back On Unnecessary Antibiotics Given To Chickens